| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,808,000 | 1,885,000 | 1,854,000 | 1,920,000 | | Cost of Revenue | (2,148,000) | 1,134,000 | 1,014,000 | (3,432,000) | | | Gross Profit |
-
| 751,000 | 840,000 | 5,352,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,691,000 | 466,000 | 397,000 | 5,031,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 56,000 | 58,000 | 60,000 | 65,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 209,000 | 227,000 | 383,000 | 256,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 9,000 | (11,000) | (48,000) | | Earnings Before Interest And Taxes | 210,000 | 236,000 | 372,000 | 208,000 | | Interest Expense | 32,000 | 26,000 | 29,000 | 30,000 | | Income Before Tax | 178,000 | 210,000 | 343,000 | 178,000 | | Income Tax Expense | 85,000 | 57,000 | 108,000 | 51,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 131,000 | 153,000 | 235,000 | 127,000 | | | Non-recurring Events | | Discontinued Operations | 3,000 | 2,000 | 50,000 | (133,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 109,000 | 155,000 | 285,000 | (6,000) | | Preferred Stock And Other Adjustments | 11,000 | (6,000) | (5,000) |
-
| | | Net Income Applicable To Common Shares | $120,000 | $149,000 | $280,000 | ($6,000) |
|
0.17% Nasdaq 
Income Statement
